Cystic fibrosis-related diabetes testing in Rottofreno
Find health labs to test for Cystic fibrosis-related diabetes in Rottofreno and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Lab - Analisi Cliniche
Via Paolo Borsellino, 1, 26865 San Rocco al Porto LO, Italia
7.4 km
Diabetes Test by Irm - Indagini Ricerche Mediche
Via Torino, 19, 20123 Milano MI, Italia
33.3 km
Diabetes Test by Farmacia Vitruvio
Via Vitruvio, 39, 20124 Milano MI, Italia
33.3 km
Hemoglobin Test by Casa di Cura Ambrosiana
Piazza Monsignor Luigi Moneta, 18, 20090 Cesano Boscone MI, Italia
34.9 km
Diabetes Test by Gemini Srl - Poliambulatorio a Parma
Piazza Sisto Rosa Badalocchio, 3, 43126 Parma PR, Italia
42 km
Hemoglobin Test by Farmacia Manganelli
Via degli Alpini, 2, 24064 Grumello del Monte BG, Italia
42.8 km
Diabetes Test by Casa della Salute
Largo Milite Ignoto, 1, 16012 Busalla GE, Italia
44.8 km
Diabetes Test by Laboratorio Analisi Cliniche Valle Scrivia SRL - Busalla
Via Luigi Nino Malerba, 28, 16012 Busalla GE, Italia
44.8 km
Diabetes Test by Farmacia Gorla
Corso della Vittoria, 71, 21042 Caronno Pertusella VA, Italia
44.6 km
Hemoglobin Test by Farmacia Di Paina Di Taborelli Dr. Angelo
Viale Brianza, 14, 20833 Giussano MB, Italia
46.9 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
